HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

IL-15 immunotherapy is a viable strategy for COVID-19.

Abstract
Coronavirus disease 2019 (COVID-19) is a pulmonary inflammatory disease induced by a newly recognized coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). SARS-CoV-2 infection was detected for the first time in the city of Wuhan in China and spread all over the world at the beginning of 2020. Several millions of people have been infected with SARS-CoV-2, and almost 382,867 human deaths worldwide have been reported so far. Notably, there has been no specific, clinically approved vaccine or anti-viral treatment strategy for COVID-19. Herein, we review COVID-19, the viral replication, and its effect on promoting pulmonary fibro-inflammation via immune cell-mediated cytokine storms in humans. Several clinical trials are currently ongoing for anti-viral drugs, vaccines, and neutralizing antibodies against COVID-19. Viral clearance is the result of effective innate and adaptive immune responses. The pivotal role of interleukin (IL)-15 in viral clearance involves maintaining the balance of induced inflammatory cytokines and the homeostatic responses of natural killer and CD8+ T cells. This review presents supporting evidence of the impact of IL-15 immunotherapy on COVID-19.
AuthorsHemanth Kumar Kandikattu, Sathisha Upparahalli Venkateshaiah, Sandeep Kumar, Anil Mishra
JournalCytokine & growth factor reviews (Cytokine Growth Factor Rev) Vol. 54 Pg. 24-31 (08 2020) ISSN: 1879-0305 [Electronic] England
PMID32536564 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
CopyrightCopyright © 2020. Published by Elsevier Ltd.
Chemical References
  • Antiviral Agents
  • Cytokines
  • IL15 protein, human
  • Interleukin-15
Topics
  • Antiviral Agents (therapeutic use)
  • Betacoronavirus (drug effects, immunology)
  • CD8-Positive T-Lymphocytes (immunology)
  • COVID-19
  • Coronavirus Infections (drug therapy)
  • Cytokine Release Syndrome (drug therapy)
  • Cytokines (blood)
  • Humans
  • Immunity, Innate (immunology)
  • Immunotherapy (methods)
  • Interleukin-15 (therapeutic use)
  • Pandemics
  • Pneumonia, Viral (drug therapy)
  • SARS-CoV-2
  • Virus Replication (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: